Skip to main content

Table 1 Patient demographics and clinical characteristics within ependymoma and pilocytic astrocytoma tumor patient cohorts

From: Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas

  Ependymomas Pilocytic astrocytomas
Patients 88 80
 Male 48 42
 Female 40 38
Age (years)
 Median (Mean ± SD) 37 (35 ± 21) 9 (14 ± 14)
 Minimum 1 0
 Maximum 73 58
Follow-up for primary tumor patients
 Survivors in the end of the follow-up 60 69
 Follow-up time for survivors (m) (median (mean ± SD)) 125 (135 ± 82) 70 (111 ± 89)
 5-year residive-free survival (%) 71 82
 5-year survival (%) 82 93
Tumors 108 80
 Primary 74 73
 Second 14 5
 Third 14 1
 Fourth-sixth 6 1
Histological grade
 I 18 80
 II 68 0
 III 22 0
Topography
 Supratentorial 35 3
 Infratentorial 28 69
 Spinal 43 2
 Cranial nerve 0 6
  1. Patient age and follow-up information were calculated using primary cases. Follow-up times are shown in months (m)
  2. SD standard deviation